Articles tagged with Atrial Fibrillation
Researchers have developed a new treatment option for atrial fibrillation using bipolar radiofrequency, which shows promising results in treating the condition. The procedure can be done without using the heart-lung machine and has been tested on sheep with successful outcomes, indicating it may be safe for human patients.
Exanta demonstrated improved safety and tolerability compared to warfarin in treating patients with medium to high risk for stroke and systemic embolism. The phase III SPORTIF programme enrolled over 6,200 patients and showed promising results. Exanta is being investigated as a simpler alternative to warfarin treatment.
A new study has found that frail and elderly patients with chronic atrial fibrillation are less likely to receive stroke-preventing drugs. Warfarin lowers the risk of stroke, heart attack or death by one-fourth in this population, but underuse is common.
A new treatment approach has been developed to restore normal heart rhythms in patients with atrial fibrillation, a condition affecting over 2 million adults. Ibutilide fumarate injection prior to an electrical shock to the heart was successful in converting abnormal rhythms to normal in all study patients.
Researchers have successfully tested an implantable device called Atrioverter to treat atrial fibrillation, a condition that can lead to stroke. The device restored normal rhythm in 96% of treated individuals, offering a new treatment option for those prone to irregular heartbeats.
A Cedars-Sinai Medical Center clinical trial may offer a permanent, non-surgical cure for patients with Paroxysmal Atrial Fibrillation. Correctly identifying patients and eliminating trigger areas using radiofrequency energy could eliminate the need for long-term therapy and reduce stroke risk.
A new study found that low-risk atrial fibrillation patients who take aspirin have a lower risk of stroke compared to those on warfarin, with fewer bleeding complications. The study identified hundreds of thousands of Americans eligible for aspirin therapy and provides new insights into stroke prevention.
Despite evidence of warfarin's effectiveness, it remains underused to prevent strokes in those with atrial fibrillation. The study found that increased prescriptions from 13% to 40% between 1989 and 1993 did not lead to significant changes in usage from 1993 onwards.
A study conducted at the University of Michigan Health System found that administering amiodarone prior to elective heart surgery reduced atrial fibrillation by approximately 50%. Patients who received amiodarone experienced less discomfort, shorter hospital stays, and lower hospital costs compared to those who received a placebo.
The University of Maryland Medical Center has successfully implanted a new device that can regulate a dangerously rapid heartbeat automatically and internally. The Metrix System TM delivers a small electrical shock to the heart, making it a more comfortable alternative to external shocks.
A recent study by American Heart Association found that risk of stroke after heart attack is highest within five days. The research highlights atrial fibrillation and ST elevation as key factors increasing likelihood of a heart attack-related stroke.